<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">91757</article-id>
<article-id pub-id-type="doi">10.7554/eLife.91757</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.91757.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.3</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Stem Cells and Regenerative Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Circulating Platelets Modulate Oligodendrocyte Progenitor Cell Differentiation During Remyelination</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Philp</surname>
<given-names>Amber R</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reyes</surname>
<given-names>Carolina R</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mansilla</surname>
<given-names>Josselyne</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Amar</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valenzuela-Krugmann</surname>
<given-names>Carlos</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rawji</surname>
<given-names>Khalil S</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonzalez Martinez</surname>
<given-names>Ginez A</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dimas</surname>
<given-names>Penelope</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hinrichsen</surname>
<given-names>Bryan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ulloa-Leal</surname>
<given-names>César</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Waller</surname>
<given-names>Amie K</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bessa de Sousa</surname>
<given-names>Diana M</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Castro</surname>
<given-names>Maite A</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aigner</surname>
<given-names>Ludwig</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ehrenfeld</surname>
<given-names>Pamela</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Maria Elena</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kazanis</surname>
<given-names>Ilias</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghevaert</surname>
<given-names>Cedric</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Franklin</surname>
<given-names>Robin JM</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7895-6318</contrib-id>
<name>
<surname>Rivera</surname>
<given-names>Francisco J</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Laboratory of Stem Cells and Neuroregeneration, Institute of Anatomy, Histology and Pathology, Faculty of Medicine, Universidad Austral de Chile</institution>, Valdivia, <country>Chile</country></aff>
<aff id="a2"><label>2</label><institution>Center for Interdisciplinary Studies on the Nervous System (CISNe), Universidad Austral de Chile</institution>, Valdivia, <country>Chile</country></aff>
<aff id="a3"><label>3</label><institution>Wellcome-MRC Cambridge Stem Cell Institute &amp; Department of Clinical Neurosciences, University of Cambridge</institution>, Cambridge, <country>United Kingdom</country></aff>
<aff id="a4"><label>4</label><institution>Translational Regenerative Neurobiology Group (TReN), Molecular and Integrative Biosciences Research Program (MIBS), Faculty of Biological and Environmental Sciences, University of Helsinki</institution>, 00790 Helsinki, <country>Finland</country></aff>
<aff id="a5"><label>5</label><institution>Escuela de Ciencias Agrícolas y Veterinarias, Universidad Viña del Mar</institution>, Viña del Mar, <country>Chile</country></aff>
<aff id="a6"><label>6</label><institution>Department of Haematology and NHS Blood and Transplant, University of Cambridge</institution>, Cambridge, <country>UK</country></aff>
<aff id="a7"><label>7</label><institution>Institute of Molecular Regenerative Medicine, Paracelsus Medical University</institution>, Salzburg, <country>Austria</country></aff>
<aff id="a8"><label>8</label><institution>Instituto de Bioquímica y Microbiología</institution>, Facultad de Ciencias, <institution>Universidad Austral de Chile</institution>, Valdivia, <country>Chile</country></aff>
<aff id="a9"><label>9</label><institution>Laboratory of Cellular Pathology, Institute of Anatomy, Histology &amp; Pathology, Faculty of Medicine, Universidad Austral de Chile</institution>, Valdivia, <country>Chile</country></aff>
<aff id="a10"><label>10</label><institution>School of Life Sciences, University of Westminster</institution>, W1W 6UW, London, <country>UK</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ryu</surname>
<given-names>Vitaly</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Behrens</surname>
<given-names>Timothy E</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Oxford</institution>
</institution-wrap>
<city>Oxford</city>
<country>United Kingdom</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence</bold>: Francisco J. Rivera, PhD, Translational Regenerative Neurobiology Group, Molecular and Integrative Biosciences Research Program (MIBS), Faculty of Biological and Environmental Sciences, University of Helsinki, Viikinkaari 1, Biocentre 3, 00014 Helsinki, Finland. Phone: +358 50 598 8142, Email: <email>francisco.rivera@helsinki.fi</email></corresp>
<fn fn-type="present-address" id="n1"><p>CZ, KSR, PD, RJMF Altos Labs – Cambridge Institute of Science</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-11-01">
<day>01</day>
<month>11</month>
<year>2023</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2024-07-15">
<day>15</day>
<month>07</month>
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP91757</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-08-28">
<day>28</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-09-22">
<day>22</day>
<month>09</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.20.558582"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2023-11-01">
<day>01</day>
<month>11</month>
<year>2023</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.91757.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.91757.1.sa2">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.91757.1.sa1">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.91757.1.sa0">Reviewer #2 (Public Review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Philp et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Philp et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-91757-v2.pdf"/>
<abstract>
<title>Abstract</title><p>Revealing unknown cues that regulate oligodendrocyte progenitor cell (OPC) function in remyelination is important to optimise the development of regenerative therapies for multiple sclerosis (MS). Platelets are present in chronic non-remyelinated lesions of MS and an increase in circulating platelets has been described in experimental autoimmune encephalomyelitis (EAE) mice, an animal model for MS. However, the contribution of platelets to remyelination remains unexplored. Here we show platelet aggregation in proximity to OPCs in areas of experimental demyelination. Partial depletion of circulating platelets impaired OPC differentiation and remyelination, without altering blood-brain barrier stability and neuroinflammation. Transient exposure to platelets enhanced OPC differentiation <italic>in vitro</italic>, whereas sustained exposure suppressed this effect. In a mouse model of thrombocytosis (<italic>CALR<sup>HET</sup></italic>), there was a sustained increase in platelet aggregation together with a reduction of newly-generated oligodendrocytes following toxin-induced demyelination. These findings reveal a complex bimodal contribution of platelet to remyelination and provide insights into remyelination failure in MS.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Multiple Sclerosis</kwd>
<kwd>Remyelination</kwd>
<kwd>Oligodendrocyte Progenitor Cells</kwd>
<kwd>Platelets</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Few changes in the text (Material and Methods, Results section and Figure legend 3).</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>In the central nervous system (CNS), remyelination by newly generated oligodendrocytes is largely mediated by the differentiation of oligodendrocyte progenitor cells (OPCs). In response to demyelination, OPCs proliferate, migrate, and differentiate into remyelinating oligodendrocytes (<xref ref-type="bibr" rid="c11">Franklin &amp; ffrench-Constant, 2008</xref>). Although remyelination represents a robust regenerative response to demyelination, it fails during the progress of multiple sclerosis (MS), a CNS autoimmune demyelinating disease (<xref ref-type="bibr" rid="c30">Noseworthy <italic>et al</italic>., 2000</xref>). Unravelling the mechanisms that govern remyelination is essential to our understanding of why this important regenerative process fails in MS, as well as in guiding the development of regenerative therapies.</p>
<p>Platelets are small, anucleate cells essential for haemostatic plug formation (<xref ref-type="bibr" rid="c38">Semple <italic>et al</italic>., 2011</xref>). Platelets also display tissue-regenerative properties (<xref ref-type="bibr" rid="c31">Nurden, 2011</xref>). Several growth factors known to modulate OPCs’ responses to demyelination, such as PDGF and FGF2 (<xref ref-type="bibr" rid="c45">Woodruff <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="c28">Murtie <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="c46">Zhou <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="c6">Clemente <italic>et al</italic>., 2011</xref>; <xref ref-type="bibr" rid="c14">Hiratsuka <italic>et al</italic>., 2019</xref>), are stored in platelets (<xref ref-type="bibr" rid="c5">Chen <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c24">Lohmann <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c37">Schallmoser &amp; Strunk, 2013</xref>; <xref ref-type="bibr" rid="c44">Warnke <italic>et al</italic>., 2013</xref>). We have previously shown that platelet lysate increases neural stem / progenitor cells (NSPCs) survival, an alternative but infrequent cellular source for mature oligodendrocytes (<xref ref-type="bibr" rid="c15">Kazanis <italic>et al</italic>., 2015</xref>). Although this evidence argues in favour of a beneficial contribution of platelets to remyelination, other studies suggest a detrimental role. CD41-expressing platelets and platelet-contained molecules are found in non-remyelinated MS lesions (<xref ref-type="bibr" rid="c23">Lock <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="c13">Han <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="c21">Langer <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c40">Simon, 2012</xref>; <xref ref-type="bibr" rid="c42">Steinman, 2012</xref>). Moreover, MS patients show increased levels of circulating platelet microparticles (PMPs) (<xref ref-type="bibr" rid="c25">Marcos-Ramiro <italic>et al</italic>., 2014</xref>) and the number of PMPs are indicative of the clinical status of the disease (<xref ref-type="bibr" rid="c35">Saenz-Cuesta <italic>et al</italic>., 2014</xref>). Additionally, MS patients display high plasma levels of platelet-specific factors such as, P-selectin and PF4 that correlate with disease course and severity, respectively (<xref ref-type="bibr" rid="c2">Cananzi <italic>et al</italic>., 1987</xref>; <xref ref-type="bibr" rid="c19">Kuenz <italic>et al</italic>., 2005</xref>). In the animal model for MS, experimental autoimmune encephalomyelitis (EAE), platelet numbers within CNS increase (<xref ref-type="bibr" rid="c41">Sonia D’Souza <italic>et al</italic>., 2018</xref>). When platelets were immunodepleted before clinical onset, EAE severity is decreased (<xref ref-type="bibr" rid="c21">Langer <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c16">Kocovski <italic>et al</italic>., 2019</xref>). Here we ask whether circulating platelets regulate OPC function and how this impacts remyelination.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Circulating platelets transiently accumulate in response to demyelination and accumulate in close proximity to OPCs</title>
<p>We first assessed the distribution of platelets during remyelination. We created lysolecithin (LPC)-induced demyelinating lesions in the spinal cord white matter of wild type (WT) mice and collected tissue sections at 1-, 3-, 5-, 7-, 10 and 14-days post-lesion (dpl). We observed CD41+ platelet aggregates within and around the lesion early after demyelination (3 dpl) (p-value &lt; 0.01) (<xref rid="fig1" ref-type="fig">Figure 1A</xref> and <xref rid="fig1" ref-type="fig">B</xref>). However, this was transient as platelet aggregates subsequently decreased until no aggregates were detected at 14 dpl (<xref rid="fig1" ref-type="fig">Figure 1A</xref> and <xref rid="fig1" ref-type="fig">B</xref>). To assess whether platelet recruitment was specific to demyelination we injected PBS containing DAPI directly into the spinal cord. No signs of demyelination were observed under these conditions and platelet aggregation was minimal at 1- and 3-days post-PBS injection (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). We next evaluated the localization of platelets within the lesion. Large platelet aggregates were found within the blood vessels and within the tissue parenchyma at 5 dpl (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). Platelets often localised with Olig2<sup>+</sup> cells around blood vessels, a scaffold used by OPCs for migration (<xref ref-type="bibr" rid="c43">Tsai <italic>et al</italic>., 2016</xref>) (<xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Platelets accumulate in response to demyelination.</title>
<p>A) LPC induced demyelinating lesions in spinal cord white matter of WT mice at 1, 3, 7, and 14 dpl, stained for platelets (CD41<sup>+</sup>). Scale bar 100 μm. B) Quantification of CD41<sup>+</sup> signal within the demyelinated lesion at 1 (<italic>n=6</italic>), 3 (<italic>n=5</italic>), 5 (<italic>n=5</italic>), 7 (<italic>n=6</italic>), 10 (n=4), and 14 dpl (<italic>n=4</italic>), and in NAWM (<italic>n=3</italic>). Scale bar 50 μm. C) Platelet staining (CD41<sup>+</sup>) in spinal cord white matter injected with PBS/DAPI. D) Upper left panel: localization of platelets within blood vessels (ColIV<sup>+</sup>) and in close proximity with OPCs (Olig2<sup>+</sup>) at 5 dpl. Upper right panel: IMARIS 3D projection shows the spatial distribution of platelets. Lower panels: magnification of the IMARIS projection showing platelet aggregation within the blood (left panel) and penetration into the parenchyma (right panel). Data were analysed using one-way ANOVA. Data represent the mean ± SD. *p&lt;0.05.</p></caption>
<graphic xlink:href="558582v3_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Depletion of circulating platelets alters OPC differentiation and remyelination in vivo</title>
<p>To investigate whether circulating platelets modulate OPC function <italic>in vivo</italic>, we used a platelet depletion model (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). LPC-induced focal demyelinating lesions were performed in WT mice followed by the administration of anti-CD42b at 3 dpl and every second day to prevent further platelet recruitment (<xref ref-type="bibr" rid="c27">Morodomi <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="c8">de Sousa <italic>et al</italic>., 2023</xref>). We first confirmed that this depletion strategy leads to decreased numbers of recruited platelets, with no accumulation in the lesion (p-value &lt; 0.05) (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). At 7 dpl, there was no difference in the number of Olig2<sup>+</sup> cells within the lesion between the platelet depleted and untreated group (<xref rid="fig2" ref-type="fig">Figure 2C</xref>, upper panels, and D), indicating that platelets do not alter OPC recruitment in response to demyelination. Through the detection of CC1 expression, a marker that identifies mature oligodendrocytes (<xref rid="fig2" ref-type="fig">Figure 2C</xref>, lower panels), we found that platelet depletion significantly decreased the number and percentage of Olig2<sup>+</sup>/CC1<sup>+</sup> cells compared to untreated mice (p-value ≤ 0.05) (<xref rid="fig2" ref-type="fig">Figure 2E</xref> and <xref rid="fig2" ref-type="fig">2F</xref>), indicating that platelet depletion impairs OPC differentiation. Consistently, at 14 dpl we observed a significant decrease in the extent of remyelination (<xref rid="fig2" ref-type="fig">Figure 2G</xref> and <xref rid="fig2" ref-type="fig">2H</xref>) and the percentage of remyelinated axons compared to untreated animals (p-value &lt; 0.05) (<xref rid="fig2" ref-type="fig">Figure 2I</xref>). Previous studies have shown that decreasing the number of circulating platelets increases blood vessel leakiness (<xref ref-type="bibr" rid="c7">Cloutier <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c12">Gupta <italic>et al</italic>., 2020</xref>). To assess whether impaired OPC differentiation might be due to fibrinogen extravasation (<xref ref-type="bibr" rid="c32">Petersen <italic>et al</italic>., 2017</xref>) or enhanced demyelination due to neutrophil infiltration (<xref ref-type="bibr" rid="c34">Ruther <italic>et al</italic>., 2017</xref>), we evaluated their presence within the lesion parenchyma after platelet depletion. There were no significant differences between neutrophil (Supplementary Figure 1A and B) and fibrinogen extravasation (Supplementary Figure 1C and D) after platelet depletion at 7 dpl, indicating that remyelination impairment likely derives from low numbers of circulating platelets rather than increased vascular leakiness.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2:</label>
<caption><title>Platelet depletion impairs remyelination <italic>in vivo</italic>.</title>
<p>A) Schematic representation of the LPC-induced demyelination model coupled with platelet depletion using anti-CD42b. B) Quantitative analysis of CD41<sup>+</sup> signal at 5 dpl in untreated <italic>(n=5)</italic> and platelet depleted mice <italic>(n=3)</italic>. C) Representative images of immunofluorescence staining of oligodendroglial lineage cells in untreated and platelet depleted mice at 7 dpl using Olig2<sup>+</sup> (upper panels) and mature oligodendrocytes using Olig2<sup>+</sup>/CC1<sup>+</sup> (lower panels). Boxed areas represent high magnification images. (D-F) Quantitative analysis of oligodendroglia at 7 dpl in untreated (<italic>n=3</italic>) and platelet depleted mice (<italic>n=5</italic>). G) Representative images of toluidine blue staining of remyelination in untreated <italic>(n=5)</italic> and platelet depleted mice <italic>(n=3)</italic> at 14 dpl and (H-I) its quantification by relative ranking analysis. Data were analyzed using an Unpaired Student’s t-test or Mann-Whitney U test. Data represent mean ± SD. *p ≤0.05; ns (not significant), p &gt;0.05. Scale bars, 100 μm.</p></caption>
<graphic xlink:href="558582v3_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2c">
<title>Depletion of circulating platelets does not alter macrophage/microglia numbers and polarization during remyelination</title>
<p>Blood-borne macrophages and CNS-resident microglia are essential for OPC differentiation during remyelination (<xref ref-type="bibr" rid="c17">Kotter <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="c26">Miron <italic>et al</italic>., 2013</xref>). As platelets regulate macrophage function in neuroinflammation (<xref ref-type="bibr" rid="c20">Langer &amp; Chavakis, 2013</xref>; <xref ref-type="bibr" rid="c3">Carestia <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c33">Rolfes <italic>et al</italic>., 2020</xref>) and since platelets are located near macrophages/microglia upon demyelination (Supplementary Figure 2A), we evaluated whether platelet depletion affects these cell populations (Supplementary Figure 2B). At 10 dpl, platelet depletion did not alter the total number of IBA-1<sup>+</sup> (Supplementary Figure 2C), pro-inflammatory IBA-1<sup>+</sup>/CD16/32<sup>+</sup> (Supplementary Figure 2D) or anti-inflammatory IBA-1<sup>+</sup>/Arg-1<sup>+</sup> (Supplementary Figure 2E) macrophages/microglia present within the remyelinating lesion. Furthermore, platelet depletion did not influence macrophage/microglia phagocytic activity as no difference in myelin debris clearance, detected by Oil-red O, was observed (Supplementary Figure 2F and G). Therefore, circulating platelets likely impact OPC differentiation without interfering with macrophage/microglia numbers/polarization during remyelination.</p>
</sec>
<sec id="s2d">
<title>Transient in vitro exposure to platelets enhances OPC differentiation</title>
<p>To confirm whether transient platelet exposure directly enhances OPC differentiation, OPCs were briefly exposed to washed platelets (WP) for 3 days (pulse) and differentiation was assessed 3 days after WP withdrawal. OPCs briefly exposed to 10% WP exhibited a significant increase in the percentage of Olig2<sup>+</sup>/MBP<sup>+</sup> mature oligodendrocytes compared to the vehicle treated control (p-value &lt; 0.0001) (<xref rid="fig3" ref-type="fig">Figure 3A</xref> and <xref rid="fig3" ref-type="fig">B</xref>), indicating that transient contact to platelets directly promotes OPC differentiation. Similar increases in the proportion of Olig2<sup>+</sup>/MBP<sup>+</sup> mature oligodendrocytes were observed when OPCs were transiently exposed to 1% platelet lysate (PL) compared to vehicle-treated control, indicating that this effect is, at least in part, mediated through platelet-contained factors and direct cell-cell contact is not essential (p-value &lt; 0.05) (<xref rid="fig3" ref-type="fig">Figure 3C - D</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3:</label>
<caption><title>Prolonged exposure to platelets suppresses their ability to enhance OPC differentiation.</title>
<p>A) Representative fluorescence images of OPCs co-cultured with 1 (<italic>n=6</italic>), 5 (<italic>n=6</italic>), and 10% (<italic>n=6</italic>) washed platelets (WP) for 3 days <italic>in vitro</italic> (DIV), followed by WP removal for an additional 3 DIV (Pulse). Additionally, OPCs were co-cultured in the presence of 10% WP for 6DIV (<italic>n=5</italic>) (Sustained). Vehicle treated OPCs represents the control condition (<italic>n=6</italic>). B) Graph represents the percentage of Olig2<sup>+</sup>MBP<sup>+</sup> oligodendrocytes within the total Olig2 population (quantitative analysis of OPC differentiation). C) Representative images of OPCs exposed to 1% platelet lysate (PL) (<italic>n=5</italic>) for 6 DIV. Vehicle treated OPCs represents the control condition (<italic>n=5</italic>). D) Graph represents the quantitative analysis of OPC differentiation as in B. E) Representative images of OPCs exposed to either PL for 9 DIV (Sustained) (<italic>n=5</italic>) or 6DIV with PL followed by its removal for an additional 3 more DIV (Withdrawn) (<italic>n=5</italic>). Vehicle treated OPCs represents the control condition (<italic>n=5</italic>). F) Graph shows the quantitative analysis of OPC differentiation as in B and D. Data were analyzed using One-way Anova followed by Tukey’s post-hoc test or an un-paired t-test. Data represent the mean ± SD. *** p ≤0.001; **** p ≤0.0001; ns (not significant), p &gt;0.05. Scale bars, 50 mm.</p></caption>
<graphic xlink:href="558582v3_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>Sustained increase in circulating platelets hampers OPC differentiation during remyelination</title>
<p>Chronically-demyelinated MS lesions have been reported to contain a substantial number of platelets and their derived molecules (<xref ref-type="bibr" rid="c23">Lock <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="c13">Han <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="c21">Langer <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="c40">Simon, 2012</xref>; <xref ref-type="bibr" rid="c42">Steinman, 2012</xref>). To explore the effects of prolonged platelet exposure on OPC differentiation we conducted experiments with sustained exposure to 10% WP. Contrary to the 3-day pulse-based exposure, 6-days of sustained exposure to 10% WP suppressed the ability of platelets to enhance OPC differentiation (<xref rid="fig3" ref-type="fig">Figure 3A</xref> and <xref rid="fig3" ref-type="fig">B</xref>). Similar findings were observed upon 9-days of sustained exposure to 1% PL (<xref rid="fig3" ref-type="fig">Figure 3E</xref> and <xref rid="fig3" ref-type="fig">F</xref>), indicating effects mediated by platelet-contained factors. To test whether this effect is reversible, PL was withdrawn upon 6 days of sustained exposure, and OPC differentiation was evaluated 3 days later. Interestingly, PL withdrawal rescued the capability of platelets to enhance OPC differentiation when compared to the vehicle treated control and the sustained condition (p-value &lt; 0.0006) (<xref rid="fig3" ref-type="fig">Figure 3E - F</xref>).</p>
<p>To assess whether a permanent increase of circulating platelets may hamper OPC differentiation during remyelination, we used a conditional mouse knock-in model carrying a mutation within the calreticulin gene in a heterozygous fashion controlled by the VaV hematopoietic promoter, resulting in sustained thrombocytosis (2 to 3 times more circulating platelets) without alterations in other cell lineages (<xref ref-type="bibr" rid="c22">Li <italic>et al</italic>., 2018</xref>). We induced a demyelinating lesion by LPC injection in the spinal cord white matter of CALR<sup>HET</sup> mice and evaluated platelet recruitment and OPC differentiation. As expected, CALR<sup>HET</sup> mice showed increased levels of circulating platelets (p-value &lt; 0.01) (<xref rid="fig4" ref-type="fig">Figure 4B</xref>) as well as a higher number of recruited platelets into the lesion (p-value &lt; 0.05) (<xref rid="fig4" ref-type="fig">Figure 4A</xref> and <xref rid="fig4" ref-type="fig">C</xref>). At 10 dpl, CALR mice displayed a reduced number of mature Olig2<sup>+</sup>/CC1<sup>+</sup> oligodendrocytes (<xref rid="fig4" ref-type="fig">Figure 4D</xref> and <xref rid="fig4" ref-type="fig">F</xref>) and a significant decrease in the percentage of differentiated OPCs (p-value &lt; 0.05) (<xref rid="fig4" ref-type="fig">Figure 4G</xref>) compared to WT mice, without alterations in the total number of Olig2<sup>+</sup> cells (<xref rid="fig4" ref-type="fig">Figure 4E</xref>). Additionally, we observed a negative correlation between the number of circulating platelets in CALR<sup>HET</sup> mice with the number of mature oligodendrocytes (r= -0.75, p-value &lt; 0.01) (<xref rid="fig4" ref-type="fig">Figure 4H</xref>). Similar to the platelet depleted model, effects on OPC differentiation are not mediated by inflammation, as CALR<sup>HET</sup> mice showed no alterations in macrophage/microglia numbers/polarization during remyelination (Supplementary Figure 2B-E). These findings indicate that sustained exposure to platelets directly hampers OPC differentiation during remyelination.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4:</label>
<caption><title>A sustained increase in circulating platelets impairs remyelination <italic>in-vivo</italic>.</title>
<p>A) Representative fluorescence images of platelets (CD41<sup>+</sup>) in LPC induced demyelinating lesions of spinal cord white matter of WT and CALR<sup>HET</sup> mice at 5 and 10 dpl B) Quantification of circulating platelets in WT vs CALR<sup>HET</sup> mice at 5 (<italic>n=4 &amp; n=5, respectively</italic>), 10 ((<italic>n=5 &amp; n=6, respectively</italic>), and 14 dpl ((<italic>n=4 &amp; n=6, respectively</italic>). C) Quantification of CD41<sup>+</sup> signal in demyelinated lesions of WT vs CALR<sup>HET</sup> mice at 5 dpl (<italic>n=5 &amp; n=5</italic>, respectively) and 10 dpl (<italic>n=4 &amp; n=4</italic>, respectively). D) Representative immunofluorescence staining of oligodendroglial lineage cells in untreated and platelet depleted mice at 10 dpl using Olig2<sup>+</sup> (upper panels) and mature oligodendrocytes using Olig2<sup>+</sup>/CC1<sup>+</sup> (lower panels) (<italic>n=4</italic>). Scale bar 100 μm. (E-G) Quantitative analysis of oligodendroglia at 10 dpl. H) Correlation between the circulating platelet number with the number of Olig2<sup>+</sup>/CC1<sup>+</sup> cells within the demyelinated lesion. Data were analyzed using an unpaired t-test or Spearman’s rank correlation analysis. Data represent the mean ± SD. *p ≤0.05; ** p ≤0.001; ns (not significant), p &gt;0.05.</p></caption>
<graphic xlink:href="558582v3_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>In conclusion, our study reveals that in response to myelin damage platelets transiently accumulate within the vascular niche and locate near OPCs. While transient contact to platelets support OPC differentiation, long lasting exposure to elevated numbers of circulating platelets hampers the generation of oligodendrocytes during remyelination. These findings argue in favour of a beneficial physiological role of platelets in remyelination. However, we also highlight that sustained increased platelet counts, as occurs in MS-related conditions, negatively alter OPC function and contribute to remyelination failure in MS.</p>
<p>Although there is a need to reveal the underlying mechanism(s) by which platelets exert a bimodal action on OPC differentiation, our findings indicate that platelet-contained factors contribute to this effect. This study shows that the regeneration of oligodendrocytes rests on the transient vs sustained presence of platelets within demyelinated lesions. Platelet accumulation in MS lesions may result from blood-brain barrier damage (<xref ref-type="bibr" rid="c1">Broman, 1964</xref>; <xref ref-type="bibr" rid="c47">Zlokovic, 2008</xref>) and/or a clearance failure, but changes in their adhesiveness (<xref ref-type="bibr" rid="c36">Sanders <italic>et al</italic>., 1968</xref>) and hyperactivity observed during MS (<xref ref-type="bibr" rid="c39">Sheremata <italic>et al</italic>., 2008</xref>) may contribute to such scenario. Strategies that restore platelet function, spatially and temporally, represent a future step for developing regenerative therapies in MS.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Animals</title>
<p>All animal work at University of Cambridge complied with the requirements and regulations of the United Kingdom Home Office (Project Licenses PCOCOF291 and P667BD734). All the experiments at Universidad Austral de Chile were conducted in agreement with the Chilean Government’s Manual of Bioethics and Biosafety (CONICYT: The Chilean Commission of Scientific and Technological Research, Santiago, Chile) and according to the guidelines established by the Animal Protection Committee of the Universidad Austral de Chile (UACh). The animal study was reviewed and approved by the <italic>Comité Institucional de Cuidado y Uso de Animales (CICUA)-UACh</italic> (Report Number # 394/2020). All the experiments at University of Helsinki followed the guidelines posed by the Academy of Finland and the University of Helsinki on research ethics and integrity (under Internal License KEK23-022) and accordingly to the National Animal Ethics Committee of Finland (ELLA). Mice and rats had access to food and water <italic>ad libitum</italic> and were exposed to a 12-hour light cycle.</p>
</sec>
<sec id="s4b">
<title>Human subjects</title>
<p>Human platelets were obtained from blood samples of healthy volunteers who signed a consent form before sampling. All procedures were approved by the <italic>Comité Ético y Científico del Servicio de Salud de Valdivia</italic> (CEC-SVS) (ORD N° 510) to carry experiments at Universidad Austral de Chile and by the Ethical Committee of the University of Cambridge to perform experiments at this institution. The blood donors at Cambridge were approved by the human biology research ethics committee (reference number: HBREC.2018.13.).</p>
</sec>
<sec id="s4c">
<title>Focal demyelination lesions</title>
<p>A focal demyelinating lesion was induced in C57BL/6 and CALR<sup>HET</sup> mice between 2-4 months of age. Animals were anesthetized using Isoflurane/Oxygen (2-2.5%/1000 ml/min O<sub>2</sub>) and buprenorphine (0.05 mg/kg) was injected subcutaneously immediately before surgery. Local Lysolecithin-driven demyelination in mice was induced as previously described in (<xref ref-type="bibr" rid="c10">Fancy <italic>et al</italic>., 2009</xref>). Briefly, the spinal cord was exposed between two vertebrae of the thoracic column and demyelination was induced by injecting 1uL of 1% lysolecithin (L-lysophosphatidylcholine, Sigma) into the ventral funiculus at a rate of approximately 0.5 µl/min<sup>−1</sup>. The incision was then sutured, and the animal was left to recover in a thermally controlled chamber. Animals were monitored for 72 hours after surgery. Any signs of pain, dragging of limbs, or weight loss of more than 15% of pre-surgery weight, resulted in cessation of the experiment. Mice were sacrificed at 1, 3, 5, 7, 10, and 14 dpl by transcardial perfusion of 4% PFA or glutaraldehyde under terminal anaesthesia.</p>
</sec>
<sec id="s4d">
<title>Platelet Depletion</title>
<p>For platelet depletion, mice received an intraperitoneal injection (IP) of 0.6µg/g of antiCD42b (Emfret Analytics) (<xref ref-type="bibr" rid="c9">Evans <italic>et al</italic>., 2021</xref>), diluted in saline solution, at 3 dpl, followed by IP injections every 48 hours until the end of the experiment period. The effectiveness of platelet depletion was confirmed by measuring the number of circulating platelets using a VetAnalyzer (scil Vet abc Plus). Mice with a circulating platelet number below 200,000 platelets/uL were considered successfully depleted.</p>
</sec>
<sec id="s4e">
<title>Preparation of washed platelets and platelet lysate</title>
<p>Washed platelets (WP) were prepared as described (<xref ref-type="bibr" rid="c4">Cazenave <italic>et al</italic>., 2004</xref>). Briefly, human blood samples were taken from the median cubital vein and collected in sodium citrate followed by centrifugation for 20 mins at 120x g to separate the red blood cells from the plasma. Plasma was collected and centrifuged at 1400x g to pellet platelets. Plasma was removed without disrupting the platelet pellet. PGI<sub>2</sub> and sodium citrate were carefully added, followed by resuspension in Tyrode’s buffer. Platelet number was quantified using a Vet Analyzer and adjusted to a concentration of 1,000,000 platelets/uL. WP were used fresh, meanwhile for the platelet lysate (PL) preparation, the suspension underwent two freeze-thaw overnight cycles. Platelet fragments were then eliminated by centrifugation at 4000x g for 15 minutes and the supernatant was collected and stored at - 20°C.</p>
</sec>
<sec id="s4f">
<title>Primary OPC cultures</title>
<p>Rat OPCs were isolated as described by (<xref ref-type="bibr" rid="c29">Neumann <italic>et al</italic>., 2019</xref>). Cells were then seeded onto glass plates pre-coated with Poly-D-Lysine (PDL) in 24-well plates, with a seeding density of 7,000 cells for differentiation assays and 10,000 cells for proliferation assays. For differentiation conditions, T3 was added to the culture media. All experimental conditions were replicated using two independent technical replicates. OPCs were either subjected to various concentrations of washed platelets (1%, 5%, and 10%) or to 1% of platelet lysate of the final volume.</p>
</sec>
<sec id="s4g">
<title>Histology and Immunofluorescence</title>
<p>After transcardial perfusion with 4% PFA, tissue was post-fixed overnight in 4% PFA at 4°C. After fixation, spinal cords were left in 30% sucrose overnight. Tissue was then embedded in OCT and cut in 15um transverse sections on a Leica Cryostat. Samples were stored at - 80°C until use.</p>
<p>For immunofluorescence staining of tissues, samples were left to thaw for 30 mins and washed with PBS. Samples were blocked for 1 hour, using a blocking solution that contained; 10% horse serum, 1% bovine serum albumin, 0.1% cold fish gelatin, 0.1% Triton X-100, and 0.05% Tween 20, diluted in PBS. After blocking, samples were incubated overnight at 4°C with primary antibody diluted in PBS containing 1% bovine serum albumin, 0.1% cold fish gelatin, and 0.5% Triton X-100. The following primary antibodies were used: rat anti-CD41 (1:200 Abcam), rat anti-CD16/32 (1:200, Santa Cruz), rabbit anti-IBA1 (1:500, WAKO), rat anti-CD31 (1.300 BD Biosciences), rabbit anti-Olig2 (1:200, Abcam), rabbit anti-Ki67 (1:100, Abcam), goat anti-Arg1 (1:200, Santa Cruz), mouse anti-CC1 (1:1000, Calbiochem), rat anti-NIMP-R14 (1:200, Abcam). Samples were washed 3 times for 5mins in PBS. After washing, samples were incubated with secondary antibody and DAPI for 1 hour, diluted in the same solution as the primary antibody. Samples were washed 3 times for 5 mins in PBS. Samples were mounted with Fluromount. All secondary antibodies were diluted 1:500. For imaging of spinal cord tissue, the entire lesion area was imaged for 5 technical replicates.</p>
<p>For immunofluorescence staining of cell cultures, samples were initially washed three times with PBS for 5 mins after fixation. The cells were then blocked with 10% Donkey Serum (DKS) in PBS for 1 hour, followed by incubation with the primary antibody overnight, diluted in the same blocking solution. The following primary antibodies were utilized: Rat Anti-Myelin Basic Protein (MBP; 1:500, Biorad) and Rabbit Anti-Oligodendrocyte transcription factor 2 (Olig2; 1:500, Abcam). The cells were then washed three times with PBS 1x for 5 mins, followed by incubation with secondary antibodies, diluted in the blocking solution, for 1 hour. The cells were washed three more times with PBS 1x for 5 mins.</p>
<p>Images were captured using a Leica SP8 Laser Confocal, a Zeiss LSM 980 Confocal or an Olympus IX81FV1000. For cell culture imaging, 8-10 photos per well were quantified for each well using an automated macro in ImageJ/Fiji. For in-vivo imaging, 3-5 photos were quantified per animal by a blinded observer. For tissue image analysis and 3D reconstruction of platelet localisation, ImageJ/Fiji (version 2.1.0/1.53 h) and Imaris (Bitplane, version 9.3.1, and 9.9.0) were used.</p>
</sec>
<sec id="s4h">
<title>Oil-red O Staining</title>
<p>To analyse myelin debris clearance, tissue sections were stained with Oil-red O as previously described by (<xref ref-type="bibr" rid="c18">Kotter <italic>et al</italic>., 2005</xref>). Briefly, sections were stained with freshly prepared Oil-red O and incubated at 37 degrees for 30 mins. Slides were washed and mounted using an aqueous mounting medium. Image J was used to threshold and quantify Oil-red O images.</p>
</sec>
<sec id="s4i">
<title>Remyelination Ranking Analysis</title>
<p>For remyelination studies, tissue was fixed with 4% glutaraldehyde and embedded in resin. Semi-thin sections of the lesion were cut and stained with Toluidine Blue. Three blinded observers ranked the level of remyelination for each biological individual, giving the most remyelinated individual the highest score, and the individual with the lowest degree of remyelination the lowest. The average for each animal was calculated from the three independent observer rankings.</p>
</sec>
<sec id="s4j">
<title>Statistical Analysis</title>
<p>Statistical analysis was performed using GraphPad Prism 8. The distribution of data were first tested using a Shapiro-Wilks test. One-way ANOVA or a Kruskal Wallis one-way analysis, with the corresponding post-hoc test, were used to compared multiple groups, and a Mann-Whiteney U-test or an unpaired t-test was used to compare between groups. P-values were represented as *≤0.05, **≤0.01, ***≤0.001, ***≤0.0001.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>Funding</title>
<p>Authors would like to thank the funding support from <italic>Agencia Nacional de Investigación y Desarrollo</italic> (ANID, Chile)-FONDECYT Program Regular Grant Number 1201706 and 1161787 (both to F.J.R.), ANID-PCI Program Grant N° REDES170233 (to F.J.R.) and N° REDES180139 (to M.A.C), ANID-National Doctoral Fellowship N° 21170732 (to A.R.P) and N° 21211727 (to C.R.R). In addition, the authors would like to thank the PROFI 6 N° 336234 of the Research Council of Finland.</p>
</sec>
<sec id="d1e1257">
<title>Supporting information</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 1</label>
<caption><title>Platelet depletion does not alter BBB permeability.</title>
<p>A) Representative immunofluorescence images of neutrophils (NIMP-R14<sup>+</sup>) and B) number of neutrophils in LPC-induced white matter spinal cord lesion at 7dp in untreated (<italic>n=3</italic>) and platelet depleted mice (<italic>n=5</italic>). C) Representative immunofluorescence images of Fibrinogen and D) quantification of Fibrinogen signal within the demyelinated lesion at 7 dpl in untreated and platelet depleted mice (<italic>n=4</italic>). Scale bar 50 μm. Data were analyzed using an unpaired t-test. Data represent the mean ± SD. ns (not significant), p &gt;0.05.</p></caption>
<graphic xlink:href="558582v3_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 2</label>
<caption>
<title>Changes in circulating platelet numbers does not alter the macrophage/microglia population during remyelination.</title>
<p>A) Platelets (CD41<sup>+</sup>) are located in close proximity to the macrophage/microglia population (IBA1<sup>+</sup>) at 5 dpl. Scale bar 50 um. B) Total macrophage/microglia population (IBA-1<sup>+</sup>), M1 (CD16/32<sup>+</sup>) and M2 (Arg-1<sup>+</sup>) macrophage/microglia populations at 10 dpl and (C-E) their respective quantitative analysis in untreated (<italic>n=6</italic>), platelet depleted (<italic>n=3</italic>), and CALR<sup>HET</sup> mice (<italic>n=4</italic>). F) Representative oil-red staining of myelin debris at 10 dpl. G) Quantification of Oil-red staining in untreated (<italic>n=6</italic>) and platelet depleted mice (<italic>n=3</italic>). Scale bar 100μm. Data were analyzed using an unpaired t-test. Data represent the mean ± SD. ns (not significant), p &gt;0.05.</p>
</caption>
<graphic xlink:href="558582v3_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<ack>
<title>Acknowledgments</title>
<p>Special acknowledgments to the <italic>Comité Ético y Científico del Servicio de Salud de Valdivia</italic> (CEC-SVS) for ethical guidance and approval (ORD N° 510). The authors would like to thank the Laboratory of Chronobiology, UACh (led by Dr. Claudia Torres-Farfán) for supporting animal experimentation. We would also like to thank Dr. Alerie Guzman de la Fuente for the Fiji/ImageJ macro for <italic>in-vitro</italic> quantification.</p>
</ack>
<sec id="s6">
<title>Disclosure statement</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
<sec id="nt1">
<title>Note</title>
<p>This reviewed preprint has been updated to use the correct text; previously, a version prior to the one reviewed was presented here.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Broman</surname>, <given-names>T.</given-names></string-name> (<year>1964</year>) <article-title>Blood-Brain Barrier Damage in Multiple Sclerosis Supravital Test-Observations</article-title>. <source>Acta Neurol Scand Suppl</source>, <volume>40</volume>, SUPPL <issue>10</issue>:<fpage>21</fpage>–<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Cananzi</surname>, <given-names>A.R.</given-names></string-name>, <string-name><surname>Ferro-Milone</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Grigoletto</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Toldo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Meneghini</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Bortolon</surname>, <given-names>F.</given-names></string-name> &amp; <string-name><surname>D’Andrea</surname>, <given-names>G.</given-names></string-name> (<year>1987</year>) <article-title>Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis</article-title>. <source>Acta Neurol Scand</source>, <volume>76</volume>, <fpage>79</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Carestia</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mena</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Olexen</surname>, <given-names>C.M.</given-names></string-name>, <string-name><surname>Ortiz Wilczynski</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Negrotto</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Errasti</surname>, <given-names>A.E.</given-names></string-name>, <string-name><surname>Gomez</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Jenne</surname>, <given-names>C.N.</given-names></string-name>, <string-name><surname>Carrera Silva</surname>, <given-names>E.A.</given-names></string-name> &amp; <string-name><surname>Schattner</surname>, <given-names>M.</given-names></string-name> (<year>2019</year>) <article-title>Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Survival of Septic Mice</article-title>. <source>Cell reports</source>, <volume>28</volume>, <fpage>896</fpage>–<lpage>908 e895</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Cazenave</surname>, <given-names>J.P.</given-names></string-name>, <string-name><surname>Ohlmann</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Cassel</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Eckly</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hechler</surname>, <given-names>B.</given-names></string-name> &amp; <string-name><surname>Gachet</surname>, <given-names>C.</given-names></string-name> (<year>2004</year>) <article-title>Preparation of washed platelet suspensions from human and rodent blood</article-title>. <source>Methods in molecular biology</source>, <volume>272</volume>, <fpage>13</fpage>–<lpage>28</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>H.H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.G.</given-names></string-name>, <string-name><surname>Kong</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>F.M.</given-names></string-name> &amp; <string-name><surname>Yu</surname>, <given-names>Q.</given-names></string-name> (<year>2012</year>) <article-title>The effects of human platelet lysate on dental pulp stem cells derived from impacted human third molars</article-title>. <source>Biomaterials</source>, <volume>33</volume>, <fpage>5023</fpage>–<lpage>5035</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Clemente</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ortega</surname>, <given-names>M.C.</given-names></string-name>, <string-name><surname>Arenzana</surname>, <given-names>F.J.</given-names></string-name> &amp; <string-name><surname>de Castro</surname>, <given-names>F.</given-names></string-name> (<year>2011</year>) <article-title>FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions</article-title>. <source>The Journal of neuroscience : the official journal of the Society for Neuroscience</source>, <volume>31</volume>, <fpage>14899</fpage>–<lpage>14909</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Cloutier</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Pare</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Farndale</surname>, <given-names>R.W.</given-names></string-name>, <string-name><surname>Schumacher</surname>, <given-names>H.R.</given-names></string-name>, <string-name><surname>Nigrovic</surname>, <given-names>P.A.</given-names></string-name>, <string-name><surname>Lacroix</surname>, <given-names>S.</given-names></string-name> &amp; <string-name><surname>Boilard</surname>, <given-names>E.</given-names></string-name> (<year>2012</year>) <article-title>Platelets can enhance vascular permeability</article-title>. <source>Blood</source>, <volume>120</volume>, <fpage>1334</fpage>–<lpage>1343</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>de Sousa</surname>, <given-names>D.M.B.</given-names></string-name>, <string-name><surname>Benedetti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Altendorfer</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Mrowetz</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Unger</surname>, <given-names>M.S.</given-names></string-name>, <string-name><surname>Schallmoser</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Aigner</surname>, <given-names>L.</given-names></string-name> &amp; <string-name><surname>Kniewallner</surname>, <given-names>K.M.</given-names></string-name> (<year>2023</year>) <article-title>Immune-mediated platelet depletion augments Alzheimer’s disease neuropathological hallmarks in APP-PS1 mice</article-title>. <source>Aging (Albany NY</source><italic>)</italic>, <volume>15</volume>, <fpage>630</fpage>–<lpage>649</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Evans</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Dalby</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Foster</surname>, <given-names>H.R.</given-names></string-name>, <string-name><surname>Howard</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Waller</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Taimoor</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lawrence</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mookerjee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lehmann</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Burton</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Valdez</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Thon</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Italiano</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Moreau</surname>, <given-names>T.</given-names></string-name> &amp; <string-name><surname>Ghevaert</surname>, <given-names>C.</given-names></string-name> (<year>2021</year>) <article-title>Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors</article-title>. <source>Blood Adv</source>, <volume>5</volume>, <fpage>1977</fpage>–<lpage>1990</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Fancy</surname>, <given-names>S.P.</given-names></string-name>, <string-name><surname>Baranzini</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Yuk</surname>, <given-names>D.I.</given-names></string-name>, <string-name><surname>Irvine</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Kaing</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sanai</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Franklin</surname>, <given-names>R.J.</given-names></string-name> &amp; <string-name><surname>Rowitch</surname>, <given-names>D.H.</given-names></string-name> (<year>2009</year>) <article-title>Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS</article-title>. <source>Genes Dev</source>, <volume>23</volume>, <fpage>1571</fpage>–<lpage>1585</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Franklin</surname>, <given-names>R.J.</given-names></string-name> &amp; <string-name><surname>ffrench-Constant</surname>, <given-names>C.</given-names></string-name> (<year>2008</year>) <article-title>Remyelination in the CNS: from biology to therapy</article-title>. <source>Nature reviews. Neuroscience</source>, <volume>9</volume>, <fpage>839</fpage>–<lpage>855</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Gupta</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Konradt</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Corken</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ware</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Nieswandt</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Di Paola</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Nieman</surname>, <given-names>M.T.</given-names></string-name>, <string-name><surname>Whiteheart</surname>, <given-names>S.W.</given-names></string-name> &amp; <string-name><surname>Brass</surname>, <given-names>L.F.</given-names></string-name> (<year>2020</year>) <article-title>Hemostasis vs. homeostasis: Platelets are essential for preserving vascular barrier function in the absence of injury or inflammation</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>117</volume>, <fpage>24316</fpage>–<lpage>24325</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Han</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Hwang</surname>, <given-names>S.I.</given-names></string-name>, <string-name><surname>Roy</surname>, <given-names>D.B.</given-names></string-name>, <string-name><surname>Lundgren</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Price</surname>, <given-names>J.V.</given-names></string-name>, <string-name><surname>Ousman</surname>, <given-names>S.S.</given-names></string-name>, <string-name><surname>Fernald</surname>, <given-names>G.H.</given-names></string-name>, <string-name><surname>Gerlitz</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>W.H.</given-names></string-name>, <string-name><surname>Baranzini</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Grinnell</surname>, <given-names>B.W.</given-names></string-name>, <string-name><surname>Raine</surname>, <given-names>C.S.</given-names></string-name>, <string-name><surname>Sobel</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>D.K.</given-names></string-name> &amp; <string-name><surname>Steinman</surname>, <given-names>L.</given-names></string-name> (<year>2008</year>) <article-title>Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets</article-title>. <source>Nature</source>, <volume>451</volume>, <fpage>1076</fpage>–<lpage>1081</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Hiratsuka</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kurganov</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Furube</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Morita</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Miyata</surname>, <given-names>S.</given-names></string-name> (<year>2019</year>) <article-title>VEGF- and PDGF-dependent proliferation of oligodendrocyte progenitor cells in the medulla oblongata after LPC-induced focal demyelination</article-title>. <source>Journal of neuroimmunology</source>, <volume>332</volume>, <fpage>176</fpage>–<lpage>186</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Kazanis</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Feichtner</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lange</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rotheneichner</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hainzl</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Oller</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schallmoser</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Rohde</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Reitsamer</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Couillard-Despres</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bauer</surname>, <given-names>H.C.</given-names></string-name>, <string-name><surname>Franklin</surname>, <given-names>R.J.</given-names></string-name>, <string-name><surname>Aigner</surname>, <given-names>L.</given-names></string-name> &amp; <string-name><surname>Rivera</surname>, <given-names>F.J.</given-names></string-name> (<year>2015</year>) <article-title>Lesion-induced accumulation of platelets promotes survival of adult neural stem / progenitor cells</article-title>. <source>Experimental neurology</source>, <volume>269</volume>, <fpage>75</fpage>–<lpage>89</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Kocovski</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>D’Souza</surname>, <given-names>C.S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Dang</surname>, <given-names>P.T.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Peter</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hale</surname>, <given-names>M.W.</given-names></string-name> &amp; <string-name><surname>Orian</surname>, <given-names>J.M.</given-names></string-name> (<year>2019</year>) <article-title>Platelet Depletion is Effective in Ameliorating Anxiety-Like Behavior and Reducing the Pro-Inflammatory Environment in the Hippocampus in Murine Experimental Autoimmune Encephalomyelitis</article-title>. <source>J Clin Med</source>, <volume>8</volume>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Kotter</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.W.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>C.</given-names></string-name> &amp; <string-name><surname>Franklin</surname>, <given-names>R.J.</given-names></string-name> (<year>2006</year>) <article-title>Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation</article-title>. <source>The Journal of neuroscience : the official journal of the Society for Neuroscience</source>, <volume>26</volume>, <fpage>328</fpage>–<lpage>332</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Kotter</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>van Rooijen</surname>, <given-names>N.</given-names></string-name> &amp; <string-name><surname>Franklin</surname>, <given-names>R.J.</given-names></string-name> (<year>2005</year>) <article-title>Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression</article-title>. <source>Neurobiology of disease</source>, <volume>18</volume>, <fpage>166</fpage>–<lpage>175</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Kuenz</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lutterotti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Khalil</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ehling</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gneiss</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Deisenhammer</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Reindl</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Berger</surname>, <given-names>T.</given-names></string-name> (<year>2005</year>) <article-title>Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis</article-title>. <source>Journal of neuroimmunology</source>, <volume>167</volume>, <fpage>143</fpage>–<lpage>149</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Langer</surname>, <given-names>H.F.</given-names></string-name> &amp; <string-name><surname>Chavakis</surname>, <given-names>T.</given-names></string-name> (<year>2013</year>) <article-title>Platelets and neurovascular inflammation</article-title>. <source>Thrombosis and haemostasis</source>, <volume>110</volume>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Langer</surname>, <given-names>H.F.</given-names></string-name>, <string-name><surname>Choi</surname>, <given-names>E.Y.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Schleicher</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Chung</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Gobel</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bdeir</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Chatzigeorgiou</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bhatia</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kruhlak</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Rose</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Burns</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>K.E.</given-names></string-name>, <string-name><surname>Qu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lehrmann</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Becker</surname>, <given-names>K.G.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Simon</surname>, <given-names>D.I.</given-names></string-name>, <string-name><surname>Nieswandt</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lambris</surname>, <given-names>J.D.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Meuth</surname>, <given-names>S.G.</given-names></string-name>, <string-name><surname>Kubes</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Chavakis</surname>, <given-names>T.</given-names></string-name> (<year>2012</year>) <article-title>Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis</article-title>. <source>Circulation research</source>, <volume>110</volume>, <fpage>1202</fpage>–<lpage>1210</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Prins</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Grinfeld</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gonzalez-Arias</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Loughran</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Dovey</surname>, <given-names>O.M.</given-names></string-name>, <string-name><surname>Klampfl</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hamilton</surname>, <given-names>T.L.</given-names></string-name>, <string-name><surname>Pask</surname>, <given-names>D.C.</given-names></string-name>, <string-name><surname>Sneade</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Aungier</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ghevaert</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Vassiliou</surname>, <given-names>G.S.</given-names></string-name>, <string-name><surname>Kent</surname>, <given-names>D.G.</given-names></string-name> &amp; <string-name><surname>Green</surname>, <given-names>A.R.</given-names></string-name> (<year>2018</year>) <article-title>Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage</article-title>. <source>Blood</source>, <volume>131</volume>, <fpage>649</fpage>–<lpage>661</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Lock</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hermans</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Pedotti</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Brendolan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schadt</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Garren</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Langer-Gould</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Strober</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cannella</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Allard</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Klonowski</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Austin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lad</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kaminski</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Galli</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Oksenberg</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Raine</surname>, <given-names>C.S.</given-names></string-name>, <string-name><surname>Heller</surname>, <given-names>R.</given-names></string-name> &amp; <string-name><surname>Steinman</surname>, <given-names>L.</given-names></string-name> (<year>2002</year>) <article-title>Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis</article-title>. <source>Nature medicine</source>, <volume>8</volume>, <fpage>500</fpage>–<lpage>508</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Lohmann</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Walenda</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Hemeda</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Joussen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Drescher</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Jockenhoevel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hutschenreuter</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Zenke</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Wagner</surname>, <given-names>W.</given-names></string-name> (<year>2012</year>) <article-title>Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells</article-title>. <source>PloS one</source>, <volume>7</volume>, <fpage>e37839</fpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Marcos-Ramiro</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Oliva Nacarino</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Serrano-Pertierra</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Blanco-Gelaz</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Weksler</surname>, <given-names>B.B.</given-names></string-name>, <string-name><surname>Romero</surname>, <given-names>I.A.</given-names></string-name>, <string-name><surname>Couraud</surname>, <given-names>P.O.</given-names></string-name>, <string-name><surname>Tunon</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lopez-Larrea</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Millan</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Cernuda-Morollon</surname>, <given-names>E.</given-names></string-name> (<year>2014</year>) <article-title>Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function</article-title>. <source>BMC Neurosci</source>, <volume>15</volume>, <fpage>110</fpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Miron</surname>, <given-names>V.E.</given-names></string-name>, <string-name><surname>Boyd</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Yuen</surname>, <given-names>T.J.</given-names></string-name>, <string-name><surname>Ruckh</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Shadrach</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>van Wijngaarden</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Wagers</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Franklin</surname>, <given-names>R.J.</given-names></string-name> &amp; <string-name><surname>ffrench-Constant</surname>, <given-names>C.</given-names></string-name> (<year>2013</year>) <article-title>M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination</article-title>. <source>Nature neuroscience</source>, <volume>16</volume>, <fpage>1211</fpage>–<lpage>1218</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Morodomi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kanaji</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Won</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ruggeri</surname>, <given-names>Z.M.</given-names></string-name> &amp; <string-name><surname>Kanaji</surname>, <given-names>T.</given-names></string-name> (<year>2020</year>) <article-title>Mechanisms of anti-GPIbalpha antibody-induced thrombocytopenia in mice</article-title>. <source>Blood</source>, <volume>135</volume>, <fpage>2292</fpage>–<lpage>2301</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Murtie</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Y.X.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>T.Q.</given-names></string-name>, <string-name><surname>Vana</surname>, <given-names>A.C.</given-names></string-name> &amp; <string-name><surname>Armstrong</surname>, <given-names>R.C.</given-names></string-name> (<year>2005</year>) <article-title>PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination</article-title>. <source>Neurobiology of disease</source>, <volume>19</volume>, <fpage>171</fpage>–<lpage>182</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Neumann</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Baror</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Segel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dietmann</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rawji</surname>, <given-names>K.S.</given-names></string-name>, <string-name><surname>Foerster</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>McClain</surname>, <given-names>C.R.</given-names></string-name>, <string-name><surname>Chalut</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>van Wijngaarden</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Franklin</surname>, <given-names>R.J.M.</given-names></string-name> (<year>2019</year>) <article-title>Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells</article-title>. <source>Cell stem cell</source>, <volume>25</volume>, <fpage>473</fpage>–<lpage>485 e478</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Noseworthy</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Lucchinetti</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Rodriguez</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Weinshenker</surname>, <given-names>B.G.</given-names></string-name> (<year>2000</year>) <article-title>Multiple sclerosis</article-title>. <source>The New England journal of medicine</source>, <volume>343</volume>, <fpage>938</fpage>–<lpage>952</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Nurden</surname>, <given-names>A.T.</given-names></string-name> (<year>2011</year>) <article-title>Platelets, inflammation and tissue regeneration</article-title>. <source>Thrombosis and haemostasis</source>, <volume>105</volume> <issue><bold>Suppl 1</bold></issue>, <fpage>S13</fpage>–<lpage>33</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Petersen</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Ryu</surname>, <given-names>J.K.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Etxeberria</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bardehle</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mendiola</surname>, <given-names>A.S.</given-names></string-name>, <string-name><surname>Kamau-Devers</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Fancy</surname>, <given-names>S.P.J.</given-names></string-name>, <string-name><surname>Thor</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bushong</surname>, <given-names>E.A.</given-names></string-name>, <string-name><surname>Baeza-Raja</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Syme</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>M.D.</given-names></string-name>, <string-name><surname>Rios Coronado</surname>, <given-names>P.E.</given-names></string-name>, <string-name><surname>Meyer-Franke</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yahn</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pous</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J.K.</given-names></string-name>, <string-name><surname>Schachtrup</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Lassmann</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>E.J.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Absinta</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Reich</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Ellisman</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Rowitch</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>J.R.</given-names></string-name> &amp; <string-name><surname>Akassoglou</surname>, <given-names>K.</given-names></string-name> (<year>2017</year>) <article-title>Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage</article-title>. <source>Neuron</source>, <volume>96</volume>, <fpage>1003</fpage>–<lpage>1012 e1007</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Rolfes</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Ribeiro</surname>, <given-names>L.S.</given-names></string-name>, <string-name><surname>Hawwari</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Bottcher</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rosero</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Maasewerd</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Santos</surname>, <given-names>M.L.S.</given-names></string-name>, <string-name><surname>Prochnicki</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Silva</surname>, <given-names>C.M.S.</given-names></string-name>, <string-name><surname>Wanderley</surname>, <given-names>C.W.S.</given-names></string-name>, <string-name><surname>Rothe</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Schmidt</surname>, <given-names>S.V.</given-names></string-name>, <string-name><surname>Stunden</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Bertheloot</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rivas</surname>, <given-names>M.N.</given-names></string-name>, <string-name><surname>Fontes</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Carvalho</surname>, <given-names>L.H.</given-names></string-name>, <string-name><surname>Cunha</surname>, <given-names>F.Q.</given-names></string-name>, <string-name><surname>Latz</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Arditi</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Franklin</surname>, <given-names>B.S.</given-names></string-name> (<year>2020</year>) <article-title>Platelets Fuel the Inflammasome Activation of Innate Immune Cells</article-title>. <source>Cell reports</source>, <volume>31</volume>, <fpage>107615</fpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Ruther</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Scheld</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dreymueller</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Clarner</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kress</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Brandenburg</surname>, <given-names>L.O.</given-names></string-name>, <string-name><surname>Swartenbroekx</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hoornaert</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ponsaerts</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Fallier-Becker</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Beyer</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Rohr</surname>, <given-names>S.O.</given-names></string-name>, <string-name><surname>Schmitz</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Chrzanowski</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Hochstrasser</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Nyamoya</surname>, <given-names>S.</given-names></string-name> &amp; <string-name><surname>Kipp</surname>, <given-names>M.</given-names></string-name> (<year>2017</year>) <article-title>Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression</article-title>. <source>Glia</source>, <volume>65</volume>, <fpage>1900</fpage>–<lpage>1913</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Saenz-Cuesta</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Irizar</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Castillo-Trivino</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Munoz-Culla</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Osorio-Querejeta</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Prada</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sepulveda</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lopez-Mato</surname>, <given-names>M.P.</given-names></string-name>, <string-name><given-names>Lopez</given-names> <surname>de Munain</surname></string-name>, <string-name><given-names>A.</given-names>, <surname>Comabella</surname></string-name>, <string-name><given-names>M.</given-names>, <surname>Villar</surname></string-name>, <string-name><given-names>L.M.</given-names>, <surname>Olascoaga</surname></string-name>, <string-name><given-names>J.</given-names> &amp; <surname>Otaegui</surname></string-name>, D. (<year>2014</year>) <article-title>Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis</article-title>. <source>Biomark Med</source>, <volume>8</volume>, <fpage>653</fpage>–<lpage>661</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Sanders</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Thompson</surname>, <given-names>R.H.</given-names></string-name>, <string-name><surname>Wright</surname>, <given-names>H.P.</given-names></string-name> &amp; <string-name><surname>Zilkha</surname>, <given-names>K.J.</given-names></string-name> (<year>1968</year>) <article-title>Further studies on platelet adhesiveness and serum cholesteryl linoleate levels in multiple sclerosis</article-title>. <source>J Neurol Neurosurg Psychiatry</source>, <volume>31</volume>, <fpage>321</fpage>–<lpage>325</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Schallmoser</surname>, <given-names>K.</given-names></string-name> &amp; <string-name><surname>Strunk</surname>, <given-names>D.</given-names></string-name> (<year>2013</year>) <article-title>Generation of a pool of human platelet lysate and efficient use in cell culture</article-title>. <source>Methods in molecular biology</source>, <volume>946</volume>, <fpage>349</fpage>–<lpage>362</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Semple</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Italiano</surname>, <given-names>J.E.</given-names>, <suffix>Jr.</suffix></string-name> &amp; <string-name><surname>Freedman</surname>, <given-names>J.</given-names></string-name> (<year>2011</year>) <article-title>Platelets and the immune continuum</article-title>. <source>Nature reviews. Immunology</source>, <volume>11</volume>, <fpage>264</fpage>–<lpage>274</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Sheremata</surname>, <given-names>W.A.</given-names></string-name>, <string-name><surname>Jy</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Horstman</surname>, <given-names>L.L.</given-names></string-name>, <string-name><surname>Ahn</surname>, <given-names>Y.S.</given-names></string-name>, <string-name><surname>Alexander</surname>, <given-names>J.S.</given-names></string-name> &amp; <string-name><surname>Minagar</surname>, <given-names>A.</given-names></string-name> (<year>2008</year>) <article-title>Evidence of platelet activation in multiple sclerosis</article-title>. <source>Journal of neuroinflammation</source>, <volume>5</volume>, <fpage>27</fpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Simon</surname>, <given-names>D.I.</given-names></string-name> (<year>2012</year>) <article-title>Inflammation and vascular injury: basic discovery to drug development</article-title>. <source>Circulation journal : official journal of the Japanese Circulation Society</source>, <volume>76</volume>, <fpage>1811</fpage>–<lpage>1818</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Sonia D’Souza</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Luke Maxwell</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Trusler</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Murphy</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Crewther</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Peter</surname>, <given-names>K.</given-names></string-name> &amp; <string-name><surname>Orian</surname></string-name>, J.M. (<year>2018</year>) <article-title>Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis</article-title>. <source>Journal of neuropathology and experimental neurology</source>, <volume>77</volume>, <fpage>567</fpage>–<lpage>576</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Steinman</surname>, <given-names>L.</given-names></string-name> (<year>2012</year>) <article-title>Platelets provide a bounty of potential targets for therapy in multiple sclerosis</article-title>. <source>Circulation research</source>, <volume>110</volume>, <fpage>1157</fpage>–<lpage>1158</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Tsai</surname>, <given-names>H.H.</given-names></string-name>, <string-name><surname>Niu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Munji</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Davalos</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tien</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Kuo</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Daneman</surname>, <given-names>R.</given-names></string-name> &amp; <string-name><surname>Fancy</surname>, <given-names>S.P.</given-names></string-name> (<year>2016</year>) <article-title>Oligodendrocyte precursors migrate along vasculature in the developing nervous system</article-title>. <source>Science</source>, <volume>351</volume>, <fpage>379</fpage>–<lpage>384</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Warnke</surname>, <given-names>P.H.</given-names></string-name>, <string-name><surname>Humpe</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Strunk</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Stephens</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Warnke</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Wiltfang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Schallmoser</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Alamein</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bourke</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Heiner</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Liu</surname>, <given-names>Q.</given-names></string-name> (<year>2013</year>) <article-title>A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies</article-title>. <source>Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery</source>, <volume>41</volume>, <fpage>153</fpage>–<lpage>161</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Woodruff</surname>, <given-names>R.H.</given-names></string-name>, <string-name><surname>Fruttiger</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Richardson</surname>, <given-names>W.D.</given-names></string-name> &amp; <string-name><surname>Franklin</surname>, <given-names>R.J.M.</given-names></string-name> (<year>2004</year>) <article-title>Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination</article-title>. <source>Molecular and Cellular Neuroscience</source>, <volume>25</volume>, <fpage>252</fpage>–<lpage>262</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>, <given-names>Y.X.</given-names></string-name>, <string-name><surname>Flint</surname>, <given-names>N.C.</given-names></string-name>, <string-name><surname>Murtie</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>T.Q.</given-names></string-name> &amp; <string-name><surname>Armstrong</surname>, <given-names>R.C.</given-names></string-name> (<year>2006</year>) <article-title>Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation</article-title>. <source>Glia</source>, <volume>54</volume>, <fpage>578</fpage>–<lpage>590</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Zlokovic</surname>, <given-names>B.V.</given-names></string-name> (<year>2008</year>) <article-title>The blood-brain barrier in health and chronic neurodegenerative disorders</article-title>. <source>Neuron</source>, <volume>57</volume>, <fpage>178</fpage>–<lpage>201</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91757.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ryu</surname>
<given-names>Vitaly</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study aims to understand how the regulation of oligodendrocyte progenitor cell (OPC) remyelination and function contributes to the treatment of multiple sclerosis. The authors provide <bold>convincing</bold> evidence for the platelets mediating OPC differentiation and remyelination. This work will be of interest to several disciplines.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91757.2.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors have studied the effects of platelets in OPC biology and remyelination. For this, they used mutant mice with lower levels of platelets as a demyelinating/remyelinating scenario, as well as in a model with large numbers of circulating platelets.</p>
<p>Strengths:</p>
<p>-The work is very focused, with defined objectives.</p>
<p>
-The work is properly done.</p>
<p>Revision comments:</p>
<p>Having consulted the new version of the work by Amber et al., the modifications and the point-by-point cover letter explaining them give direct answers to my previous comments.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91757.2.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This paper examined whether circulating platelets regulate oligodendrocyte progenitor cell (OPC) differentiation for the link with multiple sclerosis (MS). They identified that the interaction with platelets enhances OPC differentiation although persistent contact inhibits the process in the long-term. The mouse model with increased platelet levels in the blood reduced mature oligodendrocytes, while how platelets might regulate OPC differentiation is not clear yet.</p>
<p>Strengths:</p>
<p>The use of both partial platelet depletion and thrombocytosis mouse models gives in vivo evidence. The presentation of platelet accumulation in a time-course manner is rigorous. The in vitro co-culture model tested the role of platelets in OPC differentiation, which was supportive of in vivo observations.</p>
<p>Revision comments:</p>
<p>Although the mechanisms are limited, the authors addressed the major experiments I suggested.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.91757.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Philp</surname>
<given-names>Amber R</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reyes</surname>
<given-names>Carolina R</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mansilla</surname>
<given-names>Josselyne</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Amar</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Chao</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valenzuela-Krugmann</surname>
<given-names>Carlos</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rawji</surname>
<given-names>Khalil S</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonzalez Martinez</surname>
<given-names>Ginez A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dimas</surname>
<given-names>Penelope</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hinrichsen</surname>
<given-names>Bryan</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ulloa-Leal</surname>
<given-names>César</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Waller</surname>
<given-names>Amie K</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bessa de Sousa</surname>
<given-names>Diana M</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Castro</surname>
<given-names>Maite A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aigner</surname>
<given-names>Ludwig</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ehrenfeld</surname>
<given-names>Pamela</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Maria Elena</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kazanis</surname>
<given-names>Ilias</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghevaert</surname>
<given-names>Cedric</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Franklin</surname>
<given-names>Robin JM</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>Francisco J</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7895-6318</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>Summary:</p>
<p>The authors have studied the effects of platelets in OPC biology and remyelination. For this, they used mutant mice with lower levels of platelets as a demyelinating/remyelinating scenario, as well as in a model with large numbers of circulating platelets.</p>
<p>Strengths:</p>
<p>-The work is very focused, with defined objectives.</p>
<p>-The work is properly done.</p>
<p>Weaknesses:</p>
<p>-There is no clear effect on a single cell type and/or mechanism involved.</p>
</disp-quote>
<p>We appreciate the reviewer’s feedback. We understand that from our in vivo studies we are unable to distinguish whether the effects of platelets are directly exerted on OPCs or indirectly through a different cell type. However, data obtained from the platelet depleted model as well as the new data provided in this revised version in CALRHet mice indicate that, at least, macrophages / microglia do not contribute to the observed effects in OPCs. In addition to this, in vitro data support the direct effects of platelets on OPC function.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>This paper examined whether circulating platelets regulate oligodendrocyte progenitor cell (OPC) differentiation for the link with multiple sclerosis (MS). They identified that the interaction with platelets enhances OPC differentiation although persistent contact inhibits the process in the longterm. The mouse model with increased platelet levels in the blood reduced mature oligodendrocytes, while how platelets might regulate OPC differentiation is not clear yet.</p>
<p>Strengths:</p>
<p>The use of both partial platelet depletion and thrombocytosis mouse models gives in vivo evidence. The presentation of platelet accumulation in a time-course manner is rigorous. The in vitro co-culture model tested the role of platelets in OPC differentiation, which was supportive of in vivo observations.</p>
<p>Weaknesses:</p>
<p>How platelets regulate OPC differentiation is not clear. What the significance of platelets is in MS progression is not clear.</p>
</disp-quote>
<p>We thank reviewer’s view and assessment of our manuscript. We understand both of the reviewer’s concerns. Firstly, we performed additional in vitro studies and we have confirmed that platelet-contained factors are, at least in part, responsible for modulating OPC differentiation and, thus, direct cell-cell contact is not essential. Secondly, in this revised version, we added references arguing that the plasma levels of platelet microparticles and platelet-specific factors correlate with MS progression and severity.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Recommendations For the Authors):</bold></p>
<p>To ameliorate the quality of their work and make it suitable for its publication in eLife, I strongly suggest the authors to:</p>
<p>(1) In vitro co-culture platelets and OPCs to check the effects on this latter cell type biology.</p>
<p>Response: We have performed in vitro studies, in which OPCs were co-cultured with washed platelets (WP). We observed that OPC differentiation was boosted after a short exposure to WP, however, prolonged exposure to WP suppressed this effect (revised Figure 3A and B). Also, our new data using platelet lysate (PL) indicate that platelet-contained molecules are responsible for this effect (revised Figure 3C and D). Finally, we showed that by removing PL after sustained exposure (6 DIV) the ability of platelets to promote OPC differentiation is rescued (revised Figure 3E and F).</p>
<p>(2) In the CALR model, can the authors check effect of chronic exposure to large numbers of platelets? Is this affecting macrophages (including their polarization)?</p>
<p>Response: Yes, compared to wild type mouse, in the CALRHET model we confirmed the presence of larger number of platelets within demyelinated lesions (Figure 4A and C). Also, in this revised version we added data showing in the CALRHET model that thrombocytosis does not affect macrophage / microglia numbers and polarization (revised Supplementary Figure 2).</p>
<p>(3) Some aspects of the Introduction section seems too old-fashioned (ex.: the use of bFGF instead of FGF2 to refer to Fibroblast Growth Factor 2), as well as it would be convenient to include more recent references on the role of FGF2 and PDGFa in OPC biology.</p>
<p>Response: We agree with the reviewer. In this revised version we have changed bFGF for FGF2 and we added more recent references addressing the role of FGF2 and PDGFa in OPC biology.</p>
<p>(4) There are some constructions and typos that could be corrected.</p>
<p>Response: We have checked language constructions as well as typos, and these have been corrected.</p>
<p>(5) Please revise spelling of some names in the bibliography list (ex.: the correct surname is ffrenchConstant, not Ffrench-Constant).</p>
</disp-quote>
<p>We have revised the spelling of names within the bibliography, and we have corrected them accordingly.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations For the Authors):</bold></p>
<p>Mechanisms of platelet-OPC interactions</p>
<p>-  transwell co-culture assay will examine if the OPC phenotype is through direct or indirect interactions with platelets;</p>
</disp-quote>
<p>We have performed additional in vitro studies, in which OPCs were exposed to platelet lysate (PL). New results indicate that a short exposure to PL can promote OPC differentiation (revised Figure 3C and D), while a sustained exposure supresses this effect (revised Figure 3E and F). These findings indicate that platelet-contained factors are, at least in part, responsible for modulating OPC differentiation and, thus, direct cell-cell contact is not essential for such an effect.</p>
<disp-quote content-type="editor-comment">
<p>-  can you revert the phenotype of OPCs co-cultured long with platelets (maturation blocked) by removing platelet (then OPC differentiate again?) to see if the phenotype is reversible or not?</p>
</disp-quote>
<p>We would like to thank the reviewer for bringing up this interesting question. We have performed additional in vitro studies to address this issue. We found that by removing PL upon 6-days of sustained exposure rescues the ability of platelets to promote OPC differentiation (revised Figure 3E and F). These findings indicate that the supressing effect of prolonged exposure to platelets in OPC differentiation is reversible.</p>
<disp-quote content-type="editor-comment">
<p>Clinical correlation</p>
<p>-  How many MS patients has an abnormal number of or exposure to platelets?</p>
<p>We have added new information in the introduction section. Indeed, previous studies have shown that MS patients display higher levels of circulating platelet microparticles (PMPs) (MarcosRamiro et al., 2014) as well as increased plasma levels of platelet-specific factors such as, P-selectin and PF4 (Cananzi et al., 1987; Kuenz et al., 2005).</p>
<p>do platelets amount correlate with diseases severeness?</p>
</disp-quote>
<p>We have added new information in the introduction section. Indeed, PMPs are indicative of the clinical status of the disease (Saenz-Cuesta et al., 2014). Also, plasma levels of P-selectin and PF4 correlate with disease course and severity, respectively (Cananzi et al., 1987; Kuenz et al., 2005).</p>
<disp-quote content-type="editor-comment">
<p>Image quantification</p>
<p>-  please state how many sections were counted. How many animals were used per condition. Is the practice of blinded observers done for each dataset?</p>
</disp-quote>
<p>We added this information in the figure legends and in methods section. We counted between 3-5 sections per lesion. We used 3 to 6 animals per experimental group and data was analysed by blinded observers.</p>
</body>
</sub-article>
</article>